Dear Industry Partners,
EDITGENE Co., Ltd. is a globally recognized leader in biotechnology, specializing in innovative gene editing technologies. Our state-of-the-art facility specializes in CRISPR technologies, supporting applications in gene editing, cell biology, and antibody validation.
EDITGENE has independently developed the CRISPR-EDITx™ platform and the Bingo™ prime editing point mutation platform, offering comprehensive solutions including CRISPR gene knockout/knockin, overexpression, endogenous point mutation, CRISPR library screening, and more. We provide a full range of gene editing products and services to meet the needs of researchers and organizations worldwide.
To date, EDITGENE has delivered high-quality gene editing solutions and products to biological research institutes, life science laboratories, pharmaceutical companies, and CROs across more than 50 countries.
As we continue to expand our global business operations, we are actively seeking partnerships with distributors and collaborators from various regions. By joining forces, we aim to enhance the accessibility of our cutting-edge gene editing technologies and services on a global scale.
We warmly welcome interested partners to reach out and explore opportunities to collaborate with EDITGENE. Together, we can drive innovation and deliver impactful solutions to the scientific community worldwide.